Cyclerion Therapeutics's total assets for Q1 2026 were $8.51M, a decrease of -14.82% from the previous quarter. CYCN total liabilities were $1.71M for the fiscal quarter, a 90.44% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.